Shanghai Institute of Materia Medica, Ph.D
Over 10 years experience in BsAb and ADC preclinical activities. He oversees the early-stage development of BsAb and BsAb ADCs
Led or participated 5 NNSFC funded innovative programs, filed over 13 patents application on various therapeutics antibodies. Played a critical role in the preclinical development of Etesevimab

M.S. from Sichuan University
Over 18 years experience in clinical development in various therapeutics areas including oncology, immune disease, respiratory and more
Took on the leading role in over 15 clinical trials across the world. Proficient in managing the entire clinical development process, with extensive experience in leading the development of clinical trials across different scales and stage

Columbia University, Ph.D in chemistry
Over 20 years of leadership and technical expertise in biologics and ADC R&D and technology platform building.
Has a successful track record in mentoring teams and advancing therapeutic biological drugs from research to clinical stage. Responsible for ADC and small molecule platform development.